Statin use significantly improved OS for men with metastatic hormone-sensitive and nonmetastatic castrate-resistant prostate ...
Niraparib is a “maintenance” drug approved to keep certain types of cancer from coming back, including ovarian cancer, ...
The platinum-resistant ovarian cancer market is expanding due to a growing unmet need, as many patients relapse after ...
Investing.com -- Vir Biotechnology Inc (NASDAQ:VIR) stock rose 4.3% Thursday after the company announced it has dosed the first patient in Part 3 of its Phase 1 clinical trial evaluating VIR-5500 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback